Skip to content

Study for Individualized Dynamic Therapy of CVS Intervened by Auricular Acupuncture Point combined with traditional Chinese medicine

Study for Individualized Dynamic Therapy of CVS Intervened by Auricular Acupuncture Point combined with traditional Chinese medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019736
Enrollment
Unknown
Registered
2018-11-26
Start date
2018-12-31
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual display terminal syndrome

Interventions

experimental group: Acupuncture + Auricular Acupoint Pressing + Qijudihuang Pill + Chinese Herbal Medicine Free Frying Granule
control group:Esculin and Digitalisglycosides Eye Drops

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In line with the above CVS diagnostic criteria for Chinese and Western medicine and deficiency of liver-yin and kidney-yin standards for Chinese medicine; 2. Use VDT more than two hours per day; 3. duration of more than three months; 4. Aged 15-65 years old men and women; 5. Voluntary as a research object, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Uncorrected ametropia and anisometropia; 2. Ocular muscle dysfunction, monocular paralysis of the eye pupil dilation, and early-stage open-angle glaucoma; 3. Eye other active lesions, such as uveitis, eye infections; 4. If anxious, Hamilton Anxiety Scale (HAMA) total score> 14 or <7 points; 5. Endocrine disorders, neurasthenia, neurosis and high blood pressure and other patients; 6. recent history of eye surgery or trauma; 7. Pregnancy, breast-feeding women and the recent planning of pregnant women and mental patients; 8. combined with cardiovascular, cerebrovascular and hematopoietic system and other serious systemic diseases; 9. Allergic constitution or known to be allergic to the drug; 10. Those who used anti-fatigue drugs within 2 weeks before the experiment; 11. Participated in clinical trials of other drugs within 4 weeks before the test.

Design outcomes

Primary

MeasureTime frame
Dry eye score and points;Visual fatigue symptom score;Hamilton Anxiety Scale (HAMA) total score;Brightness Persistence;Close tolerance with the time the eye;Chinese medicine symptom score 50% reduction rate;The main symptoms disappeared;

Countries

China

Contacts

Public ContactJieping Zeng

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

55468765@qq.com+86 15928914195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026